Ramsay Générale de Santé Past Earnings Performance
Past criteria checks 0/6
Ramsay Générale de Santé has been growing earnings at an average annual rate of 13.2%, while the Healthcare industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 7.5% per year.
Key information
13.2%
Earnings growth rate
11.9%
EPS growth rate
Healthcare Industry Growth | 13.4% |
Revenue growth rate | 7.5% |
Return on equity | 0.2% |
Net Margin | -0.2% |
Next Earnings Update | 29 Aug 2024 |
Recent past performance updates
Recent updates
Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Paint A Concerning Picture
May 29Many Still Looking Away From Ramsay Générale de Santé SA (EPA:GDS)
May 03Ramsay Générale de Santé (EPA:GDS) Seems To Be Using A Lot Of Debt
Mar 29Investors Interested In Ramsay Générale de Santé SA's (EPA:GDS) Earnings
Jan 23Ramsay Générale de Santé (EPA:GDS) Has A Somewhat Strained Balance Sheet
Oct 26Ramsay Générale de Santé (EPA:GDS) Is Reinvesting At Lower Rates Of Return
Oct 05Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?
Aug 09We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt
Jun 16The Returns At Ramsay Générale de Santé (EPA:GDS) Aren't Growing
May 27Is Now The Time To Put Ramsay Générale de Santé (EPA:GDS) On Your Watchlist?
May 06Is Ramsay Générale de Santé (EPA:GDS) Using Too Much Debt?
Mar 15Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Have Stalled
Feb 23Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?
Jan 03Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement
Nov 19Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching
Sep 13Ramsay Générale de Santé (EPA:GDS) Has Some Way To Go To Become A Multi-Bagger
Aug 09Here's Why I Think Ramsay Générale de Santé (EPA:GDS) Is An Interesting Stock
Jun 02Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing
Mar 29If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late
Feb 01Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement
Dec 05Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching
Oct 30Is Ramsay Générale de Santé (EPA:GDS) A Risky Investment?
Oct 11Ramsay Générale de Santé (EPA:GDS) Will Want To Turn Around Its Return Trends
Aug 31If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late
Jul 15These 4 Measures Indicate That Ramsay Générale de Santé (EPA:GDS) Is Using Debt Extensively
Jun 15Ramsay Générale de Santé (EPA:GDS) Will Will Want To Turn Around Its Return Trends
May 04We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt
Mar 08Should We Be Cautious About Ramsay Générale de Santé SA's (EPA:GDS) ROE Of 1.7%?
Feb 15Should We Be Excited About The Trends Of Returns At Ramsay Générale de Santé (EPA:GDS)?
Jan 19Should Ramsay Générale de Santé (EPA:GDS) Be Disappointed With Their 19% Profit?
Dec 23Here's Why Ramsay Générale de Santé's (EPA:GDS) Statutory Earnings Are Arguably Too Conservative
Dec 03Revenue & Expenses Breakdown
How Ramsay Générale de Santé makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 4,941 | -10 | 91 | 0 |
31 Dec 23 | 4,862 | -12 | 88 | 0 |
30 Sep 23 | 4,782 | 19 | 87 | 0 |
30 Jun 23 | 4,702 | 49 | 86 | 0 |
31 Mar 23 | 4,594 | 69 | 93 | 0 |
31 Dec 22 | 4,473 | 103 | 87 | 0 |
30 Sep 22 | 4,387 | 111 | 86 | 0 |
30 Jun 22 | 4,301 | 118 | 85 | 0 |
31 Mar 22 | 4,225 | 98 | 85 | 0 |
31 Dec 21 | 4,149 | 77 | 85 | 0 |
30 Sep 21 | 4,086 | 71 | 85 | 0 |
30 Jun 21 | 4,023 | 65 | 86 | 0 |
31 Mar 21 | 3,873 | 63 | 85 | 0 |
31 Dec 20 | 3,723 | 61 | 84 | 0 |
30 Sep 20 | 3,735 | 37 | 86 | 0 |
30 Jun 20 | 3,746 | 13 | 89 | 0 |
31 Mar 20 | 3,871 | 11 | 143 | 0 |
31 Dec 19 | 3,996 | 8 | 196 | 0 |
30 Sep 19 | 3,698 | 8 | 228 | 0 |
30 Jun 19 | 3,401 | 8 | 260 | 0 |
31 Mar 19 | 2,958 | 19 | 234 | 0 |
31 Dec 18 | 2,515 | 29 | 208 | 0 |
30 Sep 18 | 2,378 | 18 | 199 | 0 |
30 Jun 18 | 2,242 | 7 | 190 | 0 |
31 Mar 18 | 2,232 | 9 | 187 | 0 |
31 Dec 17 | 2,223 | 10 | 184 | 0 |
30 Sep 17 | 2,229 | 34 | 183 | 0 |
30 Jun 17 | 2,234 | 57 | 182 | 0 |
31 Mar 17 | 2,262 | 52 | 183 | 0 |
31 Dec 16 | 2,289 | 47 | 184 | 0 |
30 Sep 16 | 2,258 | 42 | 180 | 0 |
30 Jun 16 | 2,227 | 37 | 176 | 0 |
31 Dec 15 | 1,973 | 32 | 157 | 0 |
30 Sep 15 | 1,880 | 21 | 151 | 0 |
30 Jun 15 | 1,722 | -3 | 141 | 0 |
31 Dec 14 | 1,712 | 20 | 139 | 0 |
30 Sep 14 | 1,734 | 108 | 142 | 0 |
30 Jun 14 | 1,770 | 112 | 148 | 0 |
31 Mar 14 | 1,820 | 115 | 152 | 0 |
31 Dec 13 | 1,870 | 111 | 157 | 0 |
30 Sep 13 | 1,886 | 40 | 257 | 0 |
Quality Earnings: GDS is currently unprofitable.
Growing Profit Margin: GDS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GDS is unprofitable, but has reduced losses over the past 5 years at a rate of 13.2% per year.
Accelerating Growth: Unable to compare GDS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GDS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7.9%).
Return on Equity
High ROE: GDS has a negative Return on Equity (0.16%), as it is currently unprofitable.